Porcilis PRRS Lyophilisate and solvent for suspension 200ml (100 Dose)

   Product Ref: INPOR16 Category: P

Temporarily Out of Stock



Target Species Pigs. Indications for use For active immunisation of clinically healthy pigs in a PRRS virus contaminated environment, to reduce viraemia caused by infection with European strains of PRRS virus. Specific claims For finishing pigs, the effect of the virus on the respiratory system is most relevant. A significant improvement of rearing results (reduced morbidity due to PRRS infection, and a better daily growth and feed conversion) until the end of the fattening period was observed in vaccinated pigs during field trials, particularly in piglets vaccinated at 6 weeks of age. For breeding pigs, the effect of the virus on the reproductive system is most relevant. A significant improvement of the reproductive performance in PRRS virus contaminated environments and a reduction of transplacental virus transmission after challenge was observed in vaccinated pigs. The interest of vaccination with Porcilis PRRS lies in obtaining a homogeneous and high immune status against PRRS virus in a herd. Onset of immunity: 28 days post vaccination. Duration of immunity: at least 24 weeks. Contraindications Do not use in herds where the prevalence of European PRRS virus has not been established through reliable diagnostic methods. Special warnings for each target species Porcilis PRRS must only be used in PRRS virus contaminated herds, where prevalence of European PRRS virus has been established through reliable diagnostic virological methods. No data are available on the safety of the vaccine for the reproductive performance in boars. Do not use in herds where a PRRS eradication programme based on serology has been adopted. Vaccinate healthy animals only. Special precautions for use Care should be taken to avoid the introduction of the vaccine strain into an area where PRRS virus is not already present. The vaccine virus may spread to pigs in contact during 5 weeks after vaccination. The most common spreading route is via direct contact,but spreading via contaminated objects or via the air cannot be excluded. Care should be taken to avoid spread of vaccine virus from vaccinated animals to unvaccinated animals (e.g.: na
Vat Rate: 20%

Royal Mail 2nd Class / Parcel Force 48

UK to UK :Normally arrives in 2-4 business days.

UK to Ireland :Normally arrives in 4-6 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note standered delivery is none trackable , none insured , no responsabily for lose or Damage

 

----------------------------------------------------------------------------------------------------------------

 

Royal Mail First Class / Parcel Force 24

UK to UK :Normally arrives in 1-2 business days.

UK to Ireland 3-4 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note :Trackable , Royal Mail insured up to £50.

 

--------------------------------------------------------------------------------------------------------

Parcel Force Express AM Guaranteed before Midday.

UK to UK only . UP to 5KG Max Weight

Arrives next day before 12 noon, requires a signature.

 

Parcel Forcel Terms & Conditions apply

 

Important: Parcel Force advise that there are some postcodes where an extended delivery time exists, and may affect the date of delivery or the service is not available.

 

You must be logged in to write review
Category POM-V
Temperature Refrigerated
MA/VM/EU No: 01708/4637
Species
  • pig
VMD Link Product Information Database (defra.gov.uk)
NOAH Link https://www.noahcompendium.co.uk/?id=-475166
Dosage Amounts to be administered and administration route Dosage and use Reconstitute the vaccine with the corresponding adjuvanting solvent. Number of doses per vial Volume (ml) of solvent needed for Intramuscular injection Intradermal application 10 20 2 25 50 5 50 100 10 100 200 20 Before using the vaccine allow it to reach room temperature (15 °C – 25 °C) and shake well before use. Dosage Intramuscular injection: 2 ml in the neck. Intradermal application: 0.2 ml on top or to the left or right side of the neck, or along the muscles of the back, using an intradermal device. A small, transient, intradermal lump observed after the intradermal application is indicative of the appropriate vaccination technique. Vaccination scheme: A single dose is given to pigs from 2 weeks of age onwards. Finishing pigs: a single vaccination is sufficient for protection until slaughter. Breeding pigs: For gilts a (re)vaccination 2-4 weeks before mating is recommended. To maintain a high and homologous level of immunity, revaccination at regular intervals is recommended, either before each next gestation or at random at 4 month intervals. Pregnant sows should only be vaccinated after previous exposure to European PRRS virus. It is advised to vaccinate all target pigs within a herd from the earliest recommended age onwards. Maternally derived antibodies may interfere with the response to vaccination. Newly introduced PRRS virus-naïve animals (e.g. replacement gilts from PRRS virus negative herds) should be vaccinated prior to pregnancy. The vaccine may be reconstituted shortly before vaccination for simultaneous use with Porcilis M Hyo in finishing pigs from 4 weeks of age and the following instructions should be used: Porcilis PRRS Porcilis M Hyo 10 doses + 20 ml 25 doses + 50 ml 50 doses + 100 ml 100 doses + 200 ml A single dose (2 ml) of Porcilis PRRS mixed with Porcilis M Hyo is given intramuscularly in the neck. Use sterile syringes and needles or clean intradermal equipment. Overdose The effects seen after a ten-fold overdose of vaccine virus and a two-fold overdose of solvent were similar to those seen after a single dose of vaccine.
Withdrawals Zero days.